Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.49.5
PrivacidadTérminosCookiesAviso Legal
● Connected
KRMD US Equity
KORU Medical Systems, Inc.
2.97USD▲ 0.34%
Healthcare
Medical Instruments & Supplies
96)Comparar97)Tesis →
Market Cap
$137M
Shares Outstanding
46M
P/FCF (TTM)
176.6×
Revenue (TTM)
$45M
Net Income (TTM)
−$2M
FCF (TTM)
$776,653
— Annual —FY2025
Revenue
$41M
Gross Margin
62.3%
Operating Margin
-7.2%
Net Margin
-6.4%
FCF Margin
-1.1%
ROE
-15.5%
ROCE
-14.9%
Current Ratio
2.44
FCF / Share
-0.01
Book Value / Share
0.37
KRMD US Equity
2.97USD▲ 0.34%
Tesis →

KORU Medical Systems, Inc. (KRMD): análisis fundamental y valoración

KORU Medical Systems, Inc. cotiza a 2.97 USD y tiene una capitalización bursátil de $137M. En los últimos 12 meses ha facturado $45M con un margen de flujo de caja libre del -1.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNasdaqPaísUnited StatesEmpleados73Beta0.39Web↗ www.korumedical.com

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary imm…

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
176.6×
EV/EBITDA
—
EV/Revenue
—
P/Sales
3.3×
P/Book
8.0×
Rentabilidad (Último Anual)
Gross Margin
62.3%
Operating Margin
-7.2%
Net Margin
-6.4%
FCF Margin
-1.1%
ROE
-15.5%
ROCE
-14.9%
ROA
-9.3%
Effective Tax Rate
—
Métricas TTM
Revenue TTM
$45M
Gross Profit TTM
$28M
Operating Income TTM
−$2M
Net Income TTM
−$2M
FCF TTM
$776,653
EPS TTM
-0.1
Quarters Used
4
TTM Period
2025-09-30 → 2026-06-30
Solidez del Balance
Net Debt
—
Net Debt / EBITDA
—
Debt / Equity
—
Current Ratio
2.44
Interest Coverage
-247.7×
Working Capital
$12M
Book Value / Share
0.37
Net Debt / Share
—
Crecimiento (YoY)
Revenue YoY
+22.2%
Net Income YoY
+56.5%
FCF YoY
+70.9%
EPS Diluted YoY
+53.9%
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
-0.01
CapEx % Revenue
2.3%
Rev / Employee
563,388
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaKRMDMediana SectorΔ
Gross Margin62.3%57.0%+5.2%
Operating Margin-7.2%-38.6%+31.4%
Net Margin-6.4%-33.6%+27.2%
FCF Margin-1.1%-13.9%+12.7%
ROE-15.5%-40.4%+24.9%
ROA-9.3%-32.0%+22.7%
Current Ratio2.442.84-0.40
Debt / Equity—0.28—
Scoring Fundamental
Capital Allocation
4/ 8Moderada
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✓Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✗DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)